Actemra 200mg, a drug known scientifically as tocilizumab, functions as a potent therapeutical agent primarily used for the management of rheumatoid arthritis. This effective compound acts by blocking the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Additionally, Actemra exhibits effectiveness in the